The carcinogenesis index of subcutaneous benzo[a]pyrene-initiated fibrosarcomas in the genetically ‘responsive’ C3H inbred mouse strain is more than five times higher, and about 15 times higher, than that in the ‘responsive’ C57BL/6 and the ‘nonresponsive’ DBA/2 strains, respectively. Carcinogenesis indices involving F1 hybrids of these strains indicate that additional genes besides the Ah locus may cause a particular inbred strain to be more sensitive, or resistant, to benzo[a]pyrene-initiated tumors than would be expected solely on the basis of aryl hydrocarbon (benzo[a]pyrene) hydroxylase (EC 1.14.14.2) inducibility. The DNA-bound benzo[a]pyrene metabolite complexes generated by mouse liver or skin microsomes in vitro can be resolved into at least nine distinct peaks by elution of a Sephadex LH-20 column with a water-methanol gradient. Eight peaks, shown previously to be associated with increased hepatic cytochrome Pi-450 content, are greater with liver microsomes from genetically responsive C3H and C57BL/6 inbred strains and the (C57BL/6)(C3H)F1, (C3H)(DBA/2)F1 and (C57BL/6)(DBA/2)Fι hybrids than from the genetically nonresponsive DBA/2 inbred strain. All nine peaks are greater with skin microsomes in vitro from C3H and C57BL/6 than from DBA/2 mice. Benzo[a]pyrene mutagenicity in vitro with Salmonella typhimurium tester strain TA98 is increased 5- to 6-fold with liver microsomes from C3H and C57BL/6 inbred mice and the three F1 hybrids mentioned above, compared with liver microsomes from DBA/2 mice. Similar genetic differences in benzo[a]pyrene mutagenesis with the bacterial tester strain TA100 are also seen. DNA ‘repair’ – as measured by the rate at which DNA-bound benzo[a]ρyrene 4,5-oxide and the 7,8-diol-9,10-epoxides are removed from mouse skinDNA – is not significantly different between C3H and C57BL/6 mice. The K-region oxide appears to be removed from DNA nucleosides, however, at least twice as rapidly as the 7,8-diol-9,10-epoxides. Our data thus demonstrate a strikingly good correlation between genetically determined increases in peaks representing Pι-450-catalyzed benzo[a]pyrene metabolites bound to DNA and benzo[a]pyrene mutagenesis in vitro. Neither of these in vitro parameters, nor DNA repair in mouse skin in vivo, however, explains the 5- to 6-fold difference in benzo[a]pyrene carcinogenesis index between the two genetically responsive strains, C3H and C57BL/6.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.